Screening for colorectal cancer with the fecal occult blood test: A background paper

Annals of Internal Medicine

Volumn 126, Issue 10, 1997, Pages 811-822

  Ransohoff, David F ^a   Lang, Christopher A ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b University of Colorado Health Sciences Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; CANCER STAGING; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; OCCULT BLOOD; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

EID: 0030912501     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-126-10-199705150-00014     Document Type: Review

References (82)

1. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin. 1995;45:8-30.
2. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328: 1365-71.
3. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467-71.
4. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472-7.
5. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992; 84:1572-5.
6. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653-7.
7. Eddy DM. Screening for colorectal cancer. In: Common Screening Tests. Philadelphia: American College of Physicians; 1991.
8. Fleischer DE, Goldberg SB, Browning TH, Cooper JN, Friedman E, Goldner FH, et al. Detection and surveillance of colorectal cancer. JAMA. 1989;261:580-5.
9. Eddy DM. Screening for colorectal cancer. Ann Intern Med. 1990;113:373-84
10. Levin B, Murphy GP. Revision in American Cancer Society recommendations for the early detection of colorectal cancer. CA Cancer J Clin. 1992;42:296-9.
11. Knight KK, Fielding JE, Battista RN. U.S. Preventive Services Task Force. Occult blood screening for colorectal cancer. JAMA. 1989;261:586-93.
12. Periodic health examination, 1989 update: 2. Early detection of colorectal cancer and problem drinking. Can Med Assoc J. 1989;141:209-16.
13. Screening for colorectal cancer. In: Guide to Clinical Preventive Services: Report of the U.S. Preventive Services Task Force. 2d ed. Baltimore: Williams & Wilkins; 1996:89-103
14. Ullard LA, Manning WG, Peterson CE, Lurie N, Goldberg GA, Phillips CE. Preventive Medical Care: Standards, Usage, and Efficacy. Santa Monica, CA: Rand; 1986.
15. McPhee SJ, Bird JA. Implementation of cancer prevention guidelines in clinical practice. J Gen Intern Med. 1990;5(5 Suppl):S116-22.
16. Ransohoff DF, Lang CA. Sigmoidoscopic screening in the 1990s. JAMA. 1993;269:1278-81.
17. Ransohoff DF, Lang CA, Kuo HS. Colonoscopic surveillance after polypectomy: considerations of cost effectiveness. Ann Intern Med. 1991;114:177-82.
18. Ransohoff DF, Lang CA. Screening for colorectal cancer. N Engl J Med. 1991;325:37-41.
19. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594-642.
20. Wagner JL, Behney CJ, Tunis SR, Ching A. Cost-Effectiveness of Colorectal Cancer Screening in Average-Risk Adults. Washington, DC: Office of Technology Assessment: 1995:BP-H146.
21. American College of Physicians. Suggested technique for fecal occult blood testing and interpretation in colorectal cancer screening. Ann Intern Med. 1997;126:808-10.
22. Kewenter J, Brevinge H, Engaras B, Haglind E, Ahren C. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scand J Gastroenterol. 1994;29:468-73.
23. Hardcastle JD, Thomas WM, Chamberlain J, Pye G, Sheffield J, James PD, et al. Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet. 1989;1:1160-4.
24. Hardcastle JD, Justin TA. Screening high-risk groups for colorectal neoplasia. Am J Gastroenterol. 1996;91:850-2.
25. Kewenter J, Bjork S, Haglind E, Smith L, Svanvik J, Ahren C. Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer. 1988;62:645-51.
26. Kronborg O, Fenger C, Olsen J, Bech K, Sondergaard O. Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. Scand J Gastroenterol. 1989;24:599-606.
27. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med. 1996;334: 155-9.
28. St. John DJ, Young GP, Alexeyeff MA, Deacon MC, Cuthbertson AM, Macrae FA, et al. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology. 1993;104:1661-8.
29. Young GP, St. John DJ. Faecal occult blood tests: choice, usage and clinical applications. Clinical Biochemical Reviews. 1992;13:.
30. Young GP, St. John DJ. Selecting an occult blood test for use as a screening tool for large bowel cancer. In: Rozen P, Reich CB, Winawer SJ, eds. Large Bowel Cancer: Policy, Prevention, Research, and Treatment. New York: Karger; 1991:135-56. (Rozen P, Reich CB, Winawer SJ, eds; Frontiers of Gastrointestinal Research; v 18).
31. Van Dam J, Bond JH, Sivak MV Jr. Fecal occult blood screening for colorectal cancer. Arch Intern Med. 1995;155:2389-402.
32. Simon JB. The pros and cons of fecal occult blood testing for colorectal neoplasms. Cancer Metastasis Rev. 1987;6:397-411.
33. Saito H, Yoshida Y. Mass screening: Japanese perspective. In: Young G, Levin B, Rozen P, eds. Prevention and Early Detection of Colorectal Cancer: Principles and Practice. Philadelphia: WB Saunders; 1996:301-11.
34. Allison JE, Feldman R, Tekawa IS. Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value. Long-term follow-up in a large group practice setting. Ann Intern Med. 1990;112:328-33.
35. Ransohoff DF, Lang CA. Improving the fecal occult-blood test [Editorial]. N Engl J Med. 1996;334:189-90.
36. Thomas WM, Hardcastle JD, Jackson J, Pye G. Chemical and immunological testing for faecel occult blood: a comparison of two tests in symptomatic patients. Br J Cancer. 1992;65:618-20.
37. Ransohoff DF, Lang CA. Improving the fecal occult-blood test [Letter]. N Engl J Med. 1996;334:1607-8.
38. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. Improving the fecal occult-blood test [Letter]. N Engl J Med. 1996;334:1607-8.
39. Greegor DH. Occult blood testing for detection of asymptomatic colon cancer. Cancer. 1971;28:131-4.
40. Fleisher M, Winawer SJ, Zauber AG, Smith C, Schwartz MK. Accuracy of fecal occult blood test interpretation. National Polyp Study Work Group. Ann Intern Med. 1991;114:875-6.
41. Maran S, Short TP, Thomas E. Standardizing fecal occult blood testing [Letter]. Ann Intern Med. 1991;115:576-7.
42. Macrae FA, St. John DJ. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology. 1982;82(5 Pt 1):891-8.
43. Ahlquist DA, McGill DB, Fleming JL, Schwartz S, Wieand HS, Rubin J, et al. Patterns of occult bleeding in asymptomatic colorectal cancer. Cancer. 1989;63:1826-30.
44. Doran J, Hardcastle JD. Bleeding patterns in colorectal cancer: the effect of aspirin and the implications for faecal occult blood testing. Br J Surg. 1982; 69:711-3.
45. Farrands PA, Hardcastle JD. Accuracy of occult blood tests over a six-day period. Clin Oncol 1983;9:217-25
46. Greenberg PD, Cello JP, Rockey DC. Asymptomatic chronic gastrointestinal blood loss in patients taking aspirin or warfarin for cardiovascular disease. Am J Med. 1996;100:598-604
47. Savon JJ, Allen ML, DiMarino AJ Jr, Hermann GA, Krum RP. Gastrointestinal blood loss with low dose (325 mg) plain and enteric-coated aspirin administration. Am J Gastroenterol. 1995;90:581-5.
48. Fleming JL, Ahlquist DA, McGill DB, Zinsmeister AR, Ellefson RD, Schwartz S. Influence of aspirin and ethanol on fecal blood levels as determined by using the HemoQuant assay. Mayo Clin Proc 1987;62:159-63.
49. Jaffe RM, Kasten B, Young DS, MacLowry JD. False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med. 1975;83:824-6.
50. Robinson MH, Pye G, Thomas WM, Hardcastle JD, Mangham CM. Haemoccult screening for colorectal cancer: the effect of dietary restriction on compliance. Eur J Surg Oncol. 1994;20:545-8
51. Ransohoff DF, Lang CA. Small adenomas detected during fecal occult blood test screening for colorectal cancer. The impact of serendipity. JAMA. 1990; 264:76-8.
52. Lang CA, Ransohoff DF. Fecal occult blood screening for colorectal cancer. Is mortality reduced by chance selection for screening colonoscopy? JAMA. 1994;271:1011-3
53. Ahlquist DA, Wieand HA, Moertel CG, McGill DB, Loprinzi CL, O'Connell MJ, et al. Accuracy of fecal occult blood screening for colorectal neoplasia: a prospective study using Hemoccult and HemoQuant tests. JAMA. 1993;269:1262-7.
54. Barry MJ, Mulley AG, Richter JM. Effect of work-up strategy on the cost-effectiveness of fecal occult blood screening for colorectal cancer. Gastroenterology. 1987;93:301-10.
55. Kewenter J, Brevinge H. Endoscopic and surgical complications of work-up in screening for colorectal cancer. Dis Colon Rectum. 1996;39:676-80.
56. Thoeni RF, Petras A. Double-contrast barium-enema examination and endoscopy in the detection of polypoid lesions in the cecum and ascending colon. Radiology. 1982;144:257-60.
57. Ott DJ, Ablin DS, Gelfand DW, Meschan I. Predictive value of a diagnosis of colonic polyp on the double-contrast barium enema. Gastrointest Radiol. 1983;8:75-80.
58. Leinicke JL, Dodds WJ, Hogan WJ, Stewart ET. A comparison of colonoscopy and roentgenography for detecting polypoid lesions of the colon. Gastrointest Radiol. 1977;2:125-8.
59. Stewart ET. Barium enema in detection of adenomas and colorectal cancer: results of National Polyp Study and technical considerations. In: The International Workshop on Colorectal Cancer Screening. Bethesda, MD: CASET Associates; 1994: 2-17. Available from CASET Associates, 3927 Old Lee Highway, Fairfax, VA 22033.
60. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977-81.
61. Atkin WS, Cuzick J, Edwards R, Northover JM. Long-term risk of rectal and colon cancer after a negative rigid sigmoidoscopy [Abstract]. Gastroenterology. 1996;110:A486.
62. Otchy DP, Ransohoff DF, Wolff BG, Weaver A, llstrup D, Carlson H, et al. Metachronous colon cancer in persons who have had a large adenomatous polyp. Am J Gastroenterol. 1996;91:448-54.
63. Vas W, Somers S, Stevenson G. Rapid growth of carcinoma of the colon. Gastrointest Endosc. 1982;28:19-21.
64. Spiro HM. Surveillance for colonic polyps. Mt Sinai J Med. 1988;55:251-5.
65. Luk GD. Colorectal cancer screening. In: Bayless T, ed. Current Therapy in Gastroenterology and Liver Disease. Philadelphia: Marcel Decker; 1990;387-91.
66. Boland CR, Itzkowitz SH, Kim YS. Colonic polyps and the gastrointestinal polyposis syndromes. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal Disease. 4th ed. Philadelphia: WB Saunders; 1989:1483-518.
67. Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with nonfamilial colorectal polyps. The Practice Parameters Committee of the American College of Gastroenterology. Ann Intern Med. 1993;119:836-43.
68. Winawer SJ, Zauber AG, O'Brien MJ, Ho MN, Gottlieb L, Sternberg SS, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med. 1993;328:901-6.
69. Eddy DM, Nugent FW, Eddy JF, Coller J, Gilbertsen V, Gottlieb LS, et al. Screening for colorectal cancer in a high-risk population. Results of a mathematical model. Gastroenterology. 1987;92:682-92.
70. Wagner JL, Herdman RC, Wadhwa S. Cost effectiveness of colorectal cancer screening in the elderly. Ann Intern Med. 1991;115:807-17.
71. Lieberman DA, Smith FW. Screening for colon malignancy with colonoscopy. Am J Gastroenterol. 1991;86:946-51.
72. Ransohoff DF, Lang CA. Using colonoscopy to screen for colorectal cancer [Editorial]. Am J Gastroenterol. 1994;89:1765-6.
73. Rex DK, Lehman GA, Hawes RH, Ulbright TM, Smith JJ. Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology. 1991;100:64-7.
74. Rogge JD, Elmore MF, Mahoney SJ, Brown ED, Troiano FP, Wagner DR, et al. Low-cost, office-based, screening colonoscopy. Am J Gastroenterol. 1994;89:1775-80.
75. Lindfors KK, Rosenquist CJ. The cost-effectiveness of mammographic screening strategies. JAMA. 1995;274:881-4.
76. Costs and effectiveness of colorectal cancer screening in the elderly - background paper. Washington, DC: US Gov Pr Office; 1990; publication no. (OTA) BP-H-74.
77. American Cancer Society. Cancer of the colon and rectum. CA Cancer J Clin. 1980;30:18-25.
78. Fink DJ. Cancer of the colon and rectum. In: Guidelines for the Cancer-Related Checkup. Atlanta: American Cancer Society; 1991:8-16.
79. Lang CA, Ransohoff DF. Defining risk for colorectal cancer. In: Young G, Levin B, Rozen P, eds. Prevention and Early Detection of Colorectal Cancer: Principles and Practice. Philadelphia: WB Saunders; 1996:155-70.
80. St. John DJ, Young GP, McHutchison JG, Deacon MC, Alexeyeff MA. Comparison of the specificity and sensitivity of Hemoccult and HemoQuant in screening for colorectal neoplasia. Ann Intern Med. 1992;117:376-82.
81. Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science. 1992;256:102-5.
82. Sackett DL, Holland WW. Controversy in the detection of disease. Lancet. 1975;2:357-9.